Ivan Radovanovic
- Molecular Biology top 10%
- Oncology top 5%
- Genetics top 5%
- Cancer Research top 10%
- Immunology
- Co-authors
- Virginie ClémentAriel Ruiz i AltabaNicolas de TriboletPilar Sánchez‐GómezAdriano AguzziPhilippe BertolinoZhao‐Qi WangChang Zhang
- Topics
- Hedgehog Signaling Pathway Studies (2 papers)Genetics and Neurodevelopmental Disorders (2 papers)Glioma Diagnosis and Treatment (2 papers)
- Cited by
- GeneticsOncologyCancer Research
- Partner nations
- SwitzerlandCanadaGermany
In The Last Decade
Ivan Radovanovic
8 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Molecular Biology 892
- Oncology 565
- Genetics 282
- Cancer Research 242
- Immunology 145
Countries citing papers authored by Ivan Radovanovic
This map shows the geographic impact of Ivan Radovanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Radovanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Radovanovic more than expected).
Fields of papers citing papers by Ivan Radovanovic
This network shows the impact of papers produced by Ivan Radovanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Radovanovic. The network helps show where Ivan Radovanovic may publish in the future.
Co-authorship network of co-authors of Ivan Radovanovic
This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Radovanovic. A scholar is included among the top collaborators of Ivan Radovanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Radovanovic. Ivan Radovanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 52 | |
| 3 | 4 | |
| 4 | Pineal Region Tumors – Neurosurgical Review - | 0 |
| 5 | 49 | |
| 6 | HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicitybreakdown → | 843 |
| 7 | 76 | |
| 8 | 3 | |
| 9 | 119 | |
| 10 | Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. | 152 |
About Ivan Radovanovic
Ivan Radovanovic is a scholar working on Genetics, Cancer Research and Neurology, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (2 papers), Genetics and Neurodevelopmental Disorders (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (282 citations), Oncology (565 citations) and Cancer Research (242 citations). Ivan Radovanovic has collaborated with scholars based in Switzerland, Canada and Germany. Frequent co-authors include Virginie Clément, Ariel Ruiz i Altaba, Nicolas de Tribolet, Pilar Sánchez‐Gómez, Adriano Aguzzi, Philippe Bertolino, Zhao‐Qi Wang, Chang Zhang, Huguette Casse and Christoph P. Beier. Their work appears in journals such as Nature Communications, Journal of Neuroscience and Current Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.